Delaware is a hub of gene editing research, with the Gene Editing Institute at ChristianaCare — which happens to be the only gene editing institute in the country embedded in a community cancer center. It makes sense, then, that a gene editing symposium, including industry “superstars,” will be happening soon in Newark.
“Today & Tomorrow: Bringing Gene Editing Technology from Laboratory to Bedside” is happening on Feb. 6 at the ChristianaCare John H. Ammon Medical Education Center from 1:30 to 5 p.m., to be exact.
Moderated by Maiken Scott, host of WHYY’s health and science radio show The Pulse, speakers will include:
- Eric B. Kmiec, Ph.D, director of the ChristianaCare Gene Editing Institute
- Samantha Maragh, Ph.D., head of the Genome Editing Program at the National Institute of Standards & Technology
- Maritza McIntyre, Ph.D., president of Advanced Therapies Partners, LLC
- Robert Oakes, Esq., principal at Fish & Richardson
- Patrick Plues, VP of the State Government Affairs Biotechnology Innovation Organization
The program will provide an overview of the opportunities and challenges expected as genome editing becomes more commonplace, including challenges in the IP landscape, setting industry standards, anticipated challenges from a public policy perspective, and regulatory expectations and clinical objectives.
The symposium is $25 with advanced registration required.
How CRISPR research in Delaware can fight both COVID-19 and inequity in health outcomes
CRISPR gene editing in Delaware: ‘It’s bigger than just the technology’
Sign-up for daily news updates from Technical.ly Delaware